Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim resultsSham Mailankody, Shaji Kumar, Wade Lovelace et al.|Nature Medicine|2023Cited by 239
Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systemsGerry Oster, John Edelsberg, Lois Lamerato et al.|Supportive Care in Cancer|2013Cited by 164
Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal eventsMitchell R. Smith, Karim Fizazi, Robert E. Coleman et al.|Annals of Oncology|2014Cited by 145
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristicsAllan Lipton, Ada Braun, Karim Fizazi et al.|European Journal of Cancer|2015Cited by 114
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastasesRoger von Moos, Yi Qian, Jean-Jacques Body et al.|Supportive Care in Cancer|2015Cited by 79